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Preconditioning, Collateral
Recruitment and Adenosine
We read with interest the recent article by Billinger et al. (1). It
shows that the myocardial adaptation to repetitive ischemia during
percutaneous transluminal coronary angioplasty (PTCA) is par-
tially due to collateral recruitment, which accounted for 30% of the
observed variation in intracoronary ST segment shifts and is
mainly related to ischemic preconditioning. These findings are in
agreement with several previous reports by our group (2–4) and
others (5,6) using the PTCA model of ischemic preconditioning.
However, it is surprising that, by contrast to extensive evidence
supporting a prominent role for adenosine and its receptors in
mediating the cardioprotective effects of preconditioning in both
experimental (7–9) and clinical (10–12) studies, Billinger et al. (1)
failed to show pharmacologic preconditioning with adenosine
during PTCA. However, the authors measured ST segment shifts
only 1 min after the beginning of balloon inflation, a period
insufficient for the achievement of the full evolution of ST segment
shift, as previously demonstrated (6). Furthermore, for the assess-
ment of myocardial ischemia severity, Billinger et al. (1) adjusted
ST segment amplitude with QRS amplitude. This adjusted index
of myocardial ischemia remains to be validated in the experimental
setting of repeated balloon inflations, especially because during
PTCA there are changes in the QRS amplitude, which are variably
correlated (r2 5 0.29 to 0.81) with those of ST segment shifts (13).
Surprisingly, unadjusted ST segment changes, which have been
experimentally validated (14,15), are not provided. Thus, it would
be interesting to know whether the results obtained by Billinger et
al. (1) regarding the effects of adenosine on preconditioning are
confirmed when absolute ST segment changes measured after
2 min of balloon inflation are utilized. Similar considerations apply
to the relation between changes of ST segment shift and those of
collateral flow index. This would make it possible to compare their
results with those of several previous published studies on this
topic (2–6,10–12,16).
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REPLY
We thank Tomai and colleagues for their comments on our recent
investigation (1). Their reading of our report is different from the
wording as well as from the intended meaning, which was that
even in patients with only a few collateral channels, their recruit-
ment, as an adaptive mechanism to repetitive ischemia does occur.
Our study did not show that the development of ischemic
tolerance “is mainly related to ischemic preconditioning.” If col-
lateral recruitment was observed to account for 30% of the
variation in electrocardiographic ST segment shifts, the quoted
conclusion certainly cannot be drawn. It can only be suggested (as
we did in our conclusion) that ischemic preconditioning may be a
relevant factor in the development of tolerance to ischemia. It is
correct that we could not reproduce recent data from the published
reports on the effectiveness of adenosine as “preconditioner.” This
was the case despite the fact that we used a study protocol and
dosage of adenosine identical to that used by Leesar et al. in their
investigation (2). To call the three cited studies in humans on the
effect of adenosine “extensive evidence” appears slightly exagger-
ated to us.
259JACC Vol. 35, No. 1, 1999 Letters to the Editor
January 2000:257–62
